Glenmark started operations in the Asian region in 80s by setting up offices in Malaysia & Sri lanka.
The company has presence in 12 markets in the region with 3 subsidiaries in Philippines, Malaysia and Thailand and 2 branch Offices in Vietnam and Cambodia. Malaysia, Vietnam, Philippines are the key focus market for Glenmark.
Presently Malaysia is the largest subsidiary followed by Philippines for the region. More than 30 brands are sold in each of the focus markets and over 400 products are registered in the region.
|
Therapy Segments |
|
The key therapy segments for this region are |
Dermatology |
Respiratory |
Anti-infectives |
Gynecology & |
Chronic care |
|
|
Key Brands |
|
|
Five flagship brands :
Candid B |
Budesonide Inhaler |
Ascoril |
Candid Range |
Altacef |
Some other important brands are Supirocin, Glev, Flucort, Saferon and Esoz.
|
|